ask="5.25"
ask_size="500"
average_daily_volume="58318"
bid="3.06"
bid_size="1000"
book_value="1.28"
change="-0.02"
change_from_200_day_moving_average="0.08"
change_from_50_day_moving_average="0.47"
change_from_52_week_high="-3.87"
change_From_52_week_low="1.27"
change_in_percent="-0.49%"
close="4.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.38"
ebitda="-15.34M"
eps_estimate_current_year="-1.39"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="6708000"
high="4.05"
high_52_weeks="7.92"
last_trade_date="1/9/2017"
last_trade_price="4.05"
last_trade_size="186"
last_trade_time="3:59pm"
low="3.71"
low_52_weeks="2.78"
market_capitalization="49.20M"
moving_average_200_day="3.97"
moving_average_50_day="3.58"
name="Galmed Pharmaceuticals Ltd. - O"
notes="N/A"
one_year_target_price="13.40"
open="3.71"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.05%"
percent_change_from_50_day_moving_average="+13.19%"
percent_change_from_52_week_high="-48.83%"
percent_change_from_52_week_low="+45.68%"
previous_close="4.07"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.18"
price_per_sales="256.20"
revenue="193000.00"
shares_outstanding="12149000"
short_ratio="1.63"
stock_exchange="NCM"
symbol="GLMD"
volume="50013"
weeks_range_52="2.78 - 7.92"
